Ad is loading...
CRDF
Price
$2.58
Change
-$0.26 (-9.15%)
Updated
Nov 15 closing price
101 days until earnings call
VRPX
Price
$0.61
Change
-$0.03 (-4.69%)
Updated
Nov 15 closing price
Ad is loading...

CRDF vs VRPX

Header iconCRDF vs VRPX Comparison
Open Charts CRDF vs VRPXBanner chart's image
Cardiff Oncology
Price$2.58
Change-$0.26 (-9.15%)
Volume$1.32M
CapitalizationN/A
Virpax Pharmaceuticals
Price$0.61
Change-$0.03 (-4.69%)
Volume$80.51K
CapitalizationN/A
CRDF vs VRPX Comparison Chart
Loading...
CRDF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CRDF vs. VRPX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a StrongSell and VRPX is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CRDF: $2.58 vs. VRPX: $0.61)
Brand notoriety: CRDF and VRPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 165% vs. VRPX: 39%
Market capitalization -- CRDF: $131.93M vs. VRPX: $3M
CRDF [@Biotechnology] is valued at $131.93M. VRPX’s [@Biotechnology] market capitalization is $3M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green whileVRPX’s FA Score has 1 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • VRPX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRDF and VRPX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 3 TA indicator(s) are bullish while VRPX’s TA Score has 5 bullish TA indicator(s).

  • CRDF’s TA Score: 3 bullish, 6 bearish.
  • VRPX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VRPX is a better buy in the short-term than CRDF.

Price Growth

CRDF (@Biotechnology) experienced а -16.23% price change this week, while VRPX (@Biotechnology) price change was -19.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

CRDF is expected to report earnings on Feb 27, 2025.

VRPX is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRDF($132M) has a higher market cap than VRPX($3M). CRDF YTD gains are higher at: 74.324 vs. VRPX (-80.812). VRPX has higher annual earnings (EBITDA): -18.97M vs. CRDF (-44.21M). CRDF has more cash in the bank: 60.3M vs. VRPX (1.87M). VRPX has less debt than CRDF: VRPX (1.07M) vs CRDF (1.84M). CRDF has higher revenues than VRPX: CRDF (665K) vs VRPX (0).
CRDFVRPXCRDF / VRPX
Capitalization132M3M4,397%
EBITDA-44.21M-18.97M233%
Gain YTD74.324-80.812-92%
P/E RatioN/AN/A-
Revenue665K0-
Total Cash60.3M1.87M3,223%
Total Debt1.84M1.07M172%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRDFVRPX
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRDF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAAIX13.15-0.04
-0.30%
Altegris/AACA Opportunistic Real Estt I
MCVAX11.83-0.08
-0.67%
Transamerica Mid Cap Value Opps A
CBPRX11.20-0.11
-0.97%
Pioneer Balanced ESG R
LAMYX24.51-0.28
-1.13%
Lord Abbett Dividend Growth I
HYSR0.02N/A
-9.36%
SunHydrogen Inc.

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with MDGL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
-9.15%
MDGL - CRDF
46%
Loosely correlated
-4.66%
ORMP - CRDF
39%
Loosely correlated
-4.50%
VRPX - CRDF
34%
Loosely correlated
-4.72%
RGNX - CRDF
34%
Loosely correlated
-13.55%
BTAI - CRDF
34%
Loosely correlated
+9.20%
More

VRPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRPX has been loosely correlated with BOLT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VRPX jumps, then BOLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRPX
1D Price
Change %
VRPX100%
-4.72%
BOLT - VRPX
44%
Loosely correlated
-9.14%
SCPX - VRPX
37%
Loosely correlated
-8.61%
CRDF - VRPX
34%
Loosely correlated
-9.15%
RGNX - VRPX
33%
Loosely correlated
-13.55%
ACET - VRPX
32%
Poorly correlated
-9.82%
More